A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants
Clinical trial NCT04366349 · COMPLETED
Trial details
- NCT number
- NCT04366349
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2020-12-21
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.